Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]-

Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]- Suppliers list
Company Name: Chiral Quest (Suzhou) Co., Ltd.  Gold
Tel: 0512-62956066 18112603058
Email: kendoll@cqpharm.com
Company Name: Pushan Industry (Shaanxi) Co., Ltd  Gold
Tel: 029-81310890 18165209495
Email: 2929288192@qq.com
Company Name: Adamas Reagent, Ltd.  
Tel: 400-6009262 15618770481
Email: yhx@titansci.com
Company Name: Anhui nuoquan pharmaceutical co. LTD  
Tel: 15705561919
Email: chunli.yi@nuozhanchem.com
Company Name: SHANGHAI YINGRUI CHEMICAL TECHNOLOGY CO.,LTD.  
Tel: 21-33585366 13311639313
Email: sales@shyrchem.com

Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]- manufacturers

Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]- Basic information
Product Name:Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]-
Synonyms:1,1-Dicyano-2-methoxy-2-(4-phenoxyphenyl)ethene;2-[Methoxy(4-phenoxyphenyl)methylene]propanedinitrile;Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]-;2-[(4-phenoxy-phenyl)-methoxy-methylene]-malononitrile;Intermediate of Ibrutinib, Note separate 2-[(4-phenoxy-phenyl)-methoxy-methylene]-malononitrile;2-(Methoxy(4- phenoxyphenyl)Methylene)Malononitri;ROPANEDINITRILE, 2-[METHOXY(4-PHENOXYPHENYL)METHYLENE]-;Zanubrutinib Related Compound 3
CAS:330792-69-3
MF:C17H12N2O2
MW:276.29
EINECS:
Product Categories:
Mol File:330792-69-3.mol
Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]- Structure
Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]- Chemical Properties
Boiling point 471.1±45.0 °C(Predicted)
density 1.199±0.06 g/cm3(Predicted)
storage temp. 2-8°C
AppearanceLight yellow to yellow Solid
InChIInChI=1S/C17H12N2O2/c1-20-17(14(11-18)12-19)13-7-9-16(10-8-13)21-15-5-3-2-4-6-15/h2-10H,1H3
InChIKeyIRVRZQLHMPWLLY-UHFFFAOYSA-N
SMILESC(#N)/C(=C(/OC)\C1=CC=C(OC2=CC=CC=C2)C=C1)/C#N
Safety Information
MSDS Information
Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]- Usage And Synthesis
Synthesis
4-PHENOXYBENZOYL CHLORIDE

1623-95-6

Dimethyl sulfate

77-78-1

Malononitrile

109-77-3

Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]-

330792-69-3

6.6 g of malononitrile (0.1 mol), 4.8 g of sodium hydride (0.2 mol, 80% dispersed in paraffin) and 100 mL of freshly treated anhydrous tetrahydrofuran were added to a three-neck flask. Under stirring conditions, 50 mL of tetrahydrofuran solution containing 4-phenoxybenzoyl chloride (23.2 g, 0.1 mol) was slowly added dropwise to the reaction system. After 2 hours of reaction at room temperature, 250 mL of 1 M dilute hydrochloric acid was added and stirring was continued for 30 minutes, followed by three extractions with ethyl acetate. The organic phases were combined, dried over anhydrous magnesium sulfate and concentrated to give a solid. The solid was dissolved in a mixture of 150 mL of dioxane and 50 mL of saturated sodium bicarbonate solution, followed by the addition of dimethyl sulfate (37.8 g, 0.3 mol), and the reaction mixture was heated to 80 °C. The reaction was stirred at 90 °C for 3 h. The completion of the reaction was monitored by TLC. At the end of the reaction, 400 mL of deionized water was added and extracted three times with methyl tert-butyl ether. The organic phases were combined and dried over anhydrous sodium sulfate. The solvent was removed by concentration under reduced pressure and the resulting crude product was recrystallized from methanol to give 17.6 g of white solid 2-(methoxy(4-phenoxyphenyl)methylene)malononitrile in 63.8% yield.

References[1] Patent: US2016/264584, 2016, A1. Location in patent: Paragraph 0019
Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]- Preparation Products And Raw materials
Raw materials4-Phenoxybenzoyl chloride-->Dimethyl sulfate-->Malononitrile-->Trimethoxymethane-->Sodium hydride-->Mineral oil-->1,4-Dioxane-->Hydrochloric acid-->Water-->Tetrahydrofuran
Preparation Products5-aMino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile
Tag:Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]-(330792-69-3) Related Product Information
Vandetanib Vardenafil hydrochloride (1R,3R)-Methyl-1,2,3,4-tetrahydro-2-chloroacetyl-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate (R)-Zanubrutinib Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 4,5,6,7-tetrahydro-2-(4-phenoxyphenyl)-7-(4-piperidinyl)-, (7S)- tert-butyl 4-(3-cyano-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidin-7-yl)piperidine-1-carboxylate tert-butyl 4-(3-cyano-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-7-yl)piperidine-1-carboxylate Propanedinitrile, 2-[hydroxy(4-phenoxyphenyl)Methylene]- 1-Piperidinecarboxylic acid, 4-[3-(dimethylamino)-1-oxo-2-propen-1-yl]-, 1,1-dim ent-Tadalafil cis-ent-Tadalafil cis-Tadalafil 3-(4-Phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine 5-aMino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile (S)-1-Boc-3-hydroxypiperidine Chloropretadalafil Trelagliptin succinate Tadalafil